Genomtec S.A. (WSE:GMT)
Poland flag Poland · Delayed Price · Currency is PLN
4.365
+0.015 (0.34%)
Jul 24, 2026, 4:50 PM CET

Genomtec Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.044.032.321.150.490.22
Revenue Growth
292.64%73.80%102.53%135.80%124.37%964.59%
Gross Profit
5.044.032.321.150.460.16
Operating Income
-8.68-9.55-11.06-9.15-11.51-7.59
Net Income
-17.33-10.22-11.21-18.03-23.86-5.27
Earnings Per Share
-0.61-0.68-0.84-0.74-1.27-0.87
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.614.726.74.174.141.38
Total Debt
1.861.92.741.992.290.74
Net Cash (Debt)
0.742.833.962.181.850.64
Net Cash Growth
-93.39%-28.68%81.61%17.83%188.97%-89.78%
Net Cash Per Share
0.050.190.290.170.170.07

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.34-10.86-6.72-7.95-3.6-5.5
Capital Expenditures
0.070.090.063.534.330.21
Free Cash Flow
-9.28-10.77-6.66-4.430.74-5.29
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%99.91%93.62%73.53%
Operating Margin
-172.19%-236.61%-476.30%-798.08%-2367.90%-3504.22%
Pretax Margin
-184.46%-254.64%-482.03%-788.05%-2444.86%-2655.05%
Profit Margin
-344.01%-253.40%-482.89%-1572.95%-4908.64%-2434.45%
FCF Margin
-184.10%-266.86%-286.82%-386.13%151.65%-2440.86%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----147.64-
PS Ratio
2191.9017.5845.12116.05223.89352.17